300146 Stock Overview
Develops and sells dietary supplements. More details
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 3/6 |
Past Performance | 1/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
Rewards
Risk Analysis
Byhealth Co., Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥12.93 |
52 Week High | CN¥18.49 |
52 Week Low | CN¥10.65 |
Beta | 0.62 |
11 Month Change | -1.90% |
3 Month Change | 18.08% |
1 Year Change | -29.34% |
33 Year Change | -47.84% |
5 Year Change | -13.57% |
Change since IPO | 0.15% |
Recent News & Updates
Recent updates
Shareholder Returns
300146 | CN Personal Products | CN Market | |
---|---|---|---|
7D | -0.5% | -2.0% | -3.4% |
1Y | -29.3% | -11.4% | 6.1% |
Return vs Industry: 300146 underperformed the CN Personal Products industry which returned -11.4% over the past year.
Return vs Market: 300146 underperformed the CN Market which returned 6.1% over the past year.
Price Volatility
300146 volatility | |
---|---|
300146 Average Weekly Movement | 7.9% |
Personal Products Industry Average Movement | 7.6% |
Market Average Movement | 8.2% |
10% most volatile stocks in CN Market | 12.6% |
10% least volatile stocks in CN Market | 5.5% |
Stable Share Price: 300146 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300146's weekly volatility (8%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2005 | 3,745 | Zhicheng Lin | www.by-health.com |
Byhealth Co., Ltd develops and sells dietary supplements. The company offers protein powder; collagen; bone health products, such as glucosamine, chondroitin and calcium tablets; and multivitamin products. It provides its products under the By-health, Jianli, Lifespace and other brand names through drug stores, supermarkets, maternal and child stores, distributors, retail terminals, and online channels.
Byhealth Co., Ltd Fundamentals Summary
300146 fundamental statistics | |
---|---|
Market cap | CN¥21.79b |
Earnings (TTM) | CN¥713.82m |
Revenue (TTM) | CN¥7.36b |
30.5x
P/E Ratio3.0x
P/S RatioIs 300146 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
300146 income statement (TTM) | |
---|---|
Revenue | CN¥7.36b |
Cost of Revenue | CN¥2.42b |
Gross Profit | CN¥4.94b |
Other Expenses | CN¥4.23b |
Earnings | CN¥713.82m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.42 |
Gross Margin | 67.17% |
Net Profit Margin | 9.70% |
Debt/Equity Ratio | 4.8% |
How did 300146 perform over the long term?
See historical performance and comparison